HAE
Haemonetics Corporation$77.41-2.46 (-3.07%)Prev Close$79.84·MCap$3.58B·P/E38.32·Vol808.9K·Yield—
▲
Buys (12M)
1
$98.8K
▼
Sells (12M)
2
$19.1K
◆
Net Activity
Net Buyer
$79.6K
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Haemonetics Corporation (HAE) has been dominated by buying, with 1 insider purchase totaling $98.8K and 2 insider sales totaling $19.1K. The most recent insider transaction was by KROLL MARK W (Director), who purchased $98.8K worth of shares on Nov 10, 2025. Haemonetics Corporation operates in the Healthcare sector, within the Medical - Instruments & Supplies industry, with a market cap of $3.58B.
HAE Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | KROLL MARK W | Director | Buy | 1,400 | $70.56 | $98.8K | 0 |
| Oct 31, 2025 | Galvin Roy | EVP, Chief Commercial Officer | Sell | 145 | $50.01 | $7.3K | 0 |
| Sep 17, 2025 | Miller Laurie A. | SVP, Human Resources | Sell | 238 | $49.95 | $11.9K | 0 |
| May 30, 2025 | Basil Michelle L | EVP and General Counsel | Sell | 7,469 | $69.38 | $518.2K | 0 |
| May 30, 2025 | DArecca James | EVP, Chief Financial Officer | Sell | 5,864 | $69.38 | $406.8K | 0 |
| May 30, 2025 | Miller Laurie A. | SVP, Human Resources | Sell | 2,283 | $69.38 | $158.4K | 0 |
| May 30, 2025 | Simon, Christopher | President & CEO | Sell | 26,234 | $69.38 | $1.82M | 0 |
| May 15, 2025 | Basil Michelle L | EVP and General Counsel | Sell | 2,779 | $70.10 | $194.8K | 0 |
| May 15, 2025 | DArecca James | EVP, Chief Financial Officer | Sell | 1,246 | $70.31 | $87.6K | 0 |
| May 15, 2025 | Galvin Roy | President, Global Plasma & BC | Sell | 458 | $69.90 | $32.0K | 0 |
| May 15, 2025 | Maunsell Farris Maryanne | VP, Chief Accounting Officer | Sell | 128 | $69.87 | $8.9K | 0 |
| May 15, 2025 | Miller Laurie A. | SVP, Human Resources | Sell | 683 | $70.03 | $47.8K | 0 |
| May 15, 2025 | Simon, Christopher | President & CEO | Sell | 9,480 | $70.08 | $664.3K | 0 |
| May 2, 2025 | DArecca James | EVP, Chief Financial Officer | Sell | 654 | $63.85 | $41.8K | 0 |
| Jul 29, 2024 | Strong Stewart W | President, Global Hospital | Sell | 4,312 | $91.15 | $393.0K | 18,196 |
| Jul 15, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | Sell | 2,215 | $90.00 | $199.3K | 21,410 |
| May 29, 2024 | Basil Michelle L | EVP and General Counsel | Sell | 12,990 | $88.08 | $1.14M | 35,351-27% |
| May 29, 2024 | Strong Stewart W | President, Global Hospital | Sell | 8,857 | $87.53 | $775.3K | 18,196-33% |
| May 21, 2024 | Basil Michelle L | EVP and General Counsel | Sell | 2,677 | $95.05 | $254.4K | 31,257 |
| May 21, 2024 | Llorens Josep | EVP, Global Manufacturing | Sell | 1,809 | $94.96 | $171.8K | 21,310 |
| May 21, 2024 | Strong Stewart W | President, Global Hospital | Sell | 686 | $95.11 | $65.2K | 18,196 |
| May 17, 2024 | Basil Michelle L | EVP and General Counsel | Sell | 985 | $96.14 | $94.7K | 30,425 |
| May 17, 2024 | Llorens Josep | EVP, Global Manufacturing | Sell | 770 | $96.14 | $74.0K | 17,172 |
| May 17, 2024 | Strong Stewart W | President, Global Hospital | Sell | 733 | $96.04 | $70.4K | 15,608 |
| May 8, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | Sell | 2,305 | $95.00 | $219.0K | 12,295 |
| Sep 13, 2023 | Lingamneni Anila | EVP, Chief Technology Officer | Sell | 2,305 | $90.00 | $207.4K | 14,495 |
| Sep 13, 2023 | Strong Stewart W | President, Global Hospital | Sell | 228 | $90.65 | $20.7K | 16,221 |
| Sep 7, 2023 | Dockendorff Charles J | Director | Sell | 10,215 | $87.68 | $895.7K | 2,226-82% |
| Jul 20, 2023 | Llorens Josep | EVP, Global Manufacturing | Sell | 4,928 | $90.00 | $443.5K | 18,463 |
| Jun 9, 2023 | Strong Stewart W | President, Global Hospital | Sell | 2,538 | $88.04 | $223.4K | 16,449 |
| Jun 1, 2023 | Lingamneni Anila | EVP, Chief Technology Officer | Sell | 2,304 | $83.33 | $192.0K | 16,800 |
| Jan 25, 2023 | Llorens Josep | EVP, Global Manufacturing | Sell | 2,391 | $90.00 | $215.2K | 17,234 |
| Oct 26, 2022 | Basil Michelle L | EVP and General Counsel | Sell | 180 | $80.39 | $14.5K | 32,455 |
| Oct 26, 2022 | Strong Stewart W | President, Global Hospital | Sell | 75 | $80.39 | $6.0K | 15,681 |
| Sep 21, 2022 | Basil Michelle L | EVP and General Counsel | Sell | 11,448 | $78.36 | $897.1K | 32,635-26% |
| Sep 21, 2022 | Miller Laurie A. | SVP, Human Resources | Sell | 212 | $76.25 | $16.2K | 12,697 |
| Sep 19, 2022 | Basil Michelle L | EVP and General Counsel | Sell | 33,798 | $77.89 | $2.63M | 41,424-45% |
| Sep 7, 2022 | Llorens Josep | EVP, Global Manufacturing | Sell | 101 | $73.78 | $7.5K | 17,234 |
| Aug 16, 2022 | KROLL MARK W | Director | Sell | 8,016 | $73.71 | $590.9K | 16,231-33% |
| Jul 6, 2022 | Miller Laurie A. | SVP, Human Resources | Sell | 42 | $66.18 | $2.8K | 12,909 |
| Jun 15, 2022 | Basil Michelle L | EVP and General Counsel | Sell | 277 | $62.60 | $17.3K | 40,635 |
| Jun 15, 2022 | Goldstein Dan | VP, Corporate Controller | Sell | 42 | $62.60 | $2.6K | 4,447 |
| Jun 15, 2022 | Miller Laurie A. | SVP, Human Resources | Sell | 30 | $62.60 | $1.9K | 12,951 |
| Jun 15, 2022 | Simon, Christopher | President & CEO | Sell | 1,148 | $62.60 | $71.9K | 213,724 |
| Jun 6, 2022 | Goldstein Dan | VP, Corporate Controller | Sell | 249 | $62.69 | $15.6K | 4,489 |
| Jun 6, 2022 | Miller Laurie A. | SVP, Human Resources | Sell | 198 | $62.69 | $12.4K | 12,981 |
| May 23, 2022 | Basil Michelle L | EVP and General Counsel | Sell | 3,258 | $59.10 | $192.5K | 40,912 |
| May 23, 2022 | Goldstein Dan | VP, Corporate Controller | Sell | 134 | $59.10 | $7.9K | 4,738 |
| May 23, 2022 | Lingamneni Anila | EVP, Chief Technology Officer | Sell | 1,384 | $59.10 | $81.8K | 17,322 |
| May 23, 2022 | Llorens Josep | EVP, Global Manufacturing | Sell | 1,418 | $59.10 | $83.8K | 17,335 |
Showing 1–50 of 90
1 / 2
HAE Insider Buying Activity
The following table shows recent insider purchases of Haemonetics Corporation (HAE) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | KROLL MARK W | Director | Buy | 1,400 | $70.56 | $98.8K | 0 |
HAE Insider Selling Activity
The following table shows recent insider sales of Haemonetics Corporation (HAE) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 31, 2025 | Galvin Roy | EVP, Chief Commercial Officer | Sell | 145 | $50.01 | $7.3K | 0 |
| Sep 17, 2025 | Miller Laurie A. | SVP, Human Resources | Sell | 238 | $49.95 | $11.9K | 0 |
| May 30, 2025 | Basil Michelle L | EVP and General Counsel | Sell | 7,469 | $69.38 | $518.2K | 0 |
| May 30, 2025 | DArecca James | EVP, Chief Financial Officer | Sell | 5,864 | $69.38 | $406.8K | 0 |
| May 30, 2025 | Miller Laurie A. | SVP, Human Resources | Sell | 2,283 | $69.38 | $158.4K | 0 |
| May 30, 2025 | Simon, Christopher | President & CEO | Sell | 26,234 | $69.38 | $1.82M | 0 |
| May 15, 2025 | Basil Michelle L | EVP and General Counsel | Sell | 2,779 | $70.10 | $194.8K | 0 |
| May 15, 2025 | DArecca James | EVP, Chief Financial Officer | Sell | 1,246 | $70.31 | $87.6K | 0 |
| May 15, 2025 | Galvin Roy | President, Global Plasma & BC | Sell | 458 | $69.90 | $32.0K | 0 |
| May 15, 2025 | Maunsell Farris Maryanne | VP, Chief Accounting Officer | Sell | 128 | $69.87 | $8.9K | 0 |
| May 15, 2025 | Miller Laurie A. | SVP, Human Resources | Sell | 683 | $70.03 | $47.8K | 0 |
| May 15, 2025 | Simon, Christopher | President & CEO | Sell | 9,480 | $70.08 | $664.3K | 0 |
| May 2, 2025 | DArecca James | EVP, Chief Financial Officer | Sell | 654 | $63.85 | $41.8K | 0 |
| Jul 29, 2024 | Strong Stewart W | President, Global Hospital | Sell | 4,312 | $91.15 | $393.0K | 18,196 |
| Jul 15, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | Sell | 2,215 | $90.00 | $199.3K | 21,410 |
| May 29, 2024 | Basil Michelle L | EVP and General Counsel | Sell | 12,990 | $88.08 | $1.14M | 35,351-27% |
| May 29, 2024 | Strong Stewart W | President, Global Hospital | Sell | 8,857 | $87.53 | $775.3K | 18,196-33% |
| May 21, 2024 | Basil Michelle L | EVP and General Counsel | Sell | 2,677 | $95.05 | $254.4K | 31,257 |
| May 21, 2024 | Llorens Josep | EVP, Global Manufacturing | Sell | 1,809 | $94.96 | $171.8K | 21,310 |
| May 21, 2024 | Strong Stewart W | President, Global Hospital | Sell | 686 | $95.11 | $65.2K | 18,196 |
| May 17, 2024 | Basil Michelle L | EVP and General Counsel | Sell | 985 | $96.14 | $94.7K | 30,425 |
| May 17, 2024 | Llorens Josep | EVP, Global Manufacturing | Sell | 770 | $96.14 | $74.0K | 17,172 |
| May 17, 2024 | Strong Stewart W | President, Global Hospital | Sell | 733 | $96.04 | $70.4K | 15,608 |
| May 8, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | Sell | 2,305 | $95.00 | $219.0K | 12,295 |
| Sep 13, 2023 | Lingamneni Anila | EVP, Chief Technology Officer | Sell | 2,305 | $90.00 | $207.4K | 14,495 |
| Sep 13, 2023 | Strong Stewart W | President, Global Hospital | Sell | 228 | $90.65 | $20.7K | 16,221 |
| Sep 7, 2023 | Dockendorff Charles J | Director | Sell | 10,215 | $87.68 | $895.7K | 2,226-82% |
| Jul 20, 2023 | Llorens Josep | EVP, Global Manufacturing | Sell | 4,928 | $90.00 | $443.5K | 18,463 |
| Jun 9, 2023 | Strong Stewart W | President, Global Hospital | Sell | 2,538 | $88.04 | $223.4K | 16,449 |
| Jun 1, 2023 | Lingamneni Anila | EVP, Chief Technology Officer | Sell | 2,304 | $83.33 | $192.0K | 16,800 |
| Jan 25, 2023 | Llorens Josep | EVP, Global Manufacturing | Sell | 2,391 | $90.00 | $215.2K | 17,234 |
| Oct 26, 2022 | Basil Michelle L | EVP and General Counsel | Sell | 180 | $80.39 | $14.5K | 32,455 |
| Oct 26, 2022 | Strong Stewart W | President, Global Hospital | Sell | 75 | $80.39 | $6.0K | 15,681 |
| Sep 21, 2022 | Basil Michelle L | EVP and General Counsel | Sell | 11,448 | $78.36 | $897.1K | 32,635-26% |
| Sep 21, 2022 | Miller Laurie A. | SVP, Human Resources | Sell | 212 | $76.25 | $16.2K | 12,697 |
| Sep 19, 2022 | Basil Michelle L | EVP and General Counsel | Sell | 33,798 | $77.89 | $2.63M | 41,424-45% |
| Sep 7, 2022 | Llorens Josep | EVP, Global Manufacturing | Sell | 101 | $73.78 | $7.5K | 17,234 |
| Aug 16, 2022 | KROLL MARK W | Director | Sell | 8,016 | $73.71 | $590.9K | 16,231-33% |
| Jul 6, 2022 | Miller Laurie A. | SVP, Human Resources | Sell | 42 | $66.18 | $2.8K | 12,909 |
| Jun 15, 2022 | Basil Michelle L | EVP and General Counsel | Sell | 277 | $62.60 | $17.3K | 40,635 |
| Jun 15, 2022 | Goldstein Dan | VP, Corporate Controller | Sell | 42 | $62.60 | $2.6K | 4,447 |
| Jun 15, 2022 | Miller Laurie A. | SVP, Human Resources | Sell | 30 | $62.60 | $1.9K | 12,951 |
| Jun 15, 2022 | Simon, Christopher | President & CEO | Sell | 1,148 | $62.60 | $71.9K | 213,724 |
| Jun 6, 2022 | Goldstein Dan | VP, Corporate Controller | Sell | 249 | $62.69 | $15.6K | 4,489 |
| Jun 6, 2022 | Miller Laurie A. | SVP, Human Resources | Sell | 198 | $62.69 | $12.4K | 12,981 |
| May 23, 2022 | Basil Michelle L | EVP and General Counsel | Sell | 3,258 | $59.10 | $192.5K | 40,912 |
| May 23, 2022 | Goldstein Dan | VP, Corporate Controller | Sell | 134 | $59.10 | $7.9K | 4,738 |
| May 23, 2022 | Lingamneni Anila | EVP, Chief Technology Officer | Sell | 1,384 | $59.10 | $81.8K | 17,322 |
| May 23, 2022 | Llorens Josep | EVP, Global Manufacturing | Sell | 1,418 | $59.10 | $83.8K | 17,335 |
HAE Insiders
Similar Stocks to HAE
BDX
Becton, Dickinson and Company
$146.75-0.41%
$54.76B
MDLN
Medline Inc.
$36.55-1.55%
$28.42B
WST
West Pharmaceutical Services, Inc.
$327.72-0.79%
$22.59B
ATR
AptarGroup, Inc.
$117.46+0.75%
$7.40B
RGEN
Repligen Corporation
$131.87-1.10%
$7.34B
AVTR
Avantor, Inc.
$9.45-2.23%
$6.77B
MMSI
Merit Medical Systems, Inc.
$66.56-0.50%
$3.99B
ICUI
ICU Medical, Inc.
$142.67-0.13%
$3.57B